lobbying_activities: 1839313

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1839313	c92f3e28-6271-47f0-af4f-4fbcbc64c226	Q2	RED+BLUE STRATEGIES	400693064	EXPRESS SCRIPTS INC.	2016	second_quarter	MMM	The Comprehensive Addiction and Recovery Act(S. 524) - Legislation focused on fighting the opioid epidemic in America, including amendments allowing the use of certain pharmacies and providers to protect Medicare beneficiaries from addiction. H.R. 2646 - The Helping Families in Mental Health Crisis Act. Focus on the impact of policies on the pharmacy benefit for Medicare and Medicaid. The Mental Health Reform Act of 2015 (S. 1945) - Legislation focused on improving treatment for mental health and substance use disorders. Particular focus on formulary policies. Implementation of the health reform law with a focus on policies and regulations related to biosimilars, prescription drug coverage in the Exchanges and related policies. Policies related to Medicare Part C and D with a focus on network design, formularies and access to specialty medications. Issues related to mail order coverage for Medicare, Medicaid, and Exchanges. ACA- related regulations impacting Federal and State Based Marketplaces'' coverage of prescription medications. Issues related to cost of and access to specialty medications and their impact on consumers and purchasers.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2016-07-11T14:43:45.277000-04:00